Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) ROCE % : 14.22% (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Jiangsu Hengrui Pharmaceuticals Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 14.22%.

Jiangsu Hengrui Pharmaceuticals Co ROCE % Historical Data

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Hengrui Pharmaceuticals Co ROCE % Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

26.88

24.63

13.38

10.66

11.69

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															13.51	11.99	12.99	8.39	14.22

Jiangsu Hengrui Pharmaceuticals Co ROCE % Calculation

Jiangsu Hengrui Pharmaceuticals Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	4673.013	/	( ( (42370.876 - 3639.22)	+	(43784.507 - 2553.659) )	/ 2 )
	=	4673.013	/	( (38731.656	+	41230.848)	/ 2 )
	=	4673.013	/	39981.252
	=	11.69 %

Jiangsu Hengrui Pharmaceuticals Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	5962.656	/	( ( (43784.507 - 2553.659)	+	(46340.001 - 3698.072) )	/ 2 )
	=	5962.656	/	( ( 41230.848	+	42641.929 )	/ 2 )
	=	5962.656	/	41936.3885
	=	14.22 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Jiangsu Hengrui Pharmaceuticals Co ROCE % Related Terms

Thank you for viewing the detailed overview of Jiangsu Hengrui Pharmaceuticals Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047

Website

http://www.hrs.com.cn

Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Headlines

No Headlines